Net profit of Fredun Pharmaceuticals rose 26.30% to Rs 5.33 crore in the quarter ended December 2024 as against Rs 4.22 crore during the previous quarter ended December 2023. Sales rose 17.53% to Rs 101.84 crore in the quarter ended December 2024 as against Rs 86.65 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 101.84 | 86.65 | 18 |
| OPM % | 12.98 | 12.14 | - |
| PBDT | 8.22 | 6.75 | 22 |
| PBT | 7.13 | 5.76 | 24 |
| NP | 5.33 | 4.22 | 26 |
Powered by Capital Market - Live News